142 related articles for article (PubMed ID: 17219256)
1. Combined cytoreductive laser therapy and immunotherapy for palliation of metastatic renal cell carcinoma to the head and neck.
Paiva MB; Sercarz JA; Pantuck AJ; Polyakov M; Figlin RA; Canalis RF; Castro DJ
Lasers Med Sci; 2007 Mar; 22(1):60-3. PubMed ID: 17219256
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience.
Franklin JR; Figlin R; Rauch J; Gitlitz B; Belldegrun A
Semin Urol Oncol; 1996 Nov; 14(4):230-6. PubMed ID: 8946623
[TBL] [Abstract][Full Text] [Related]
4. Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2.
Lissoni P; Bordin V; Vaghi M; Fumagalli L; Bordoni A; Mengo S; Bucovec R; Fumagalli E; Malugani F; Ardizzoia A; Giani L; Gardani GS; Tancini G
Anticancer Res; 2002; 22(2B):1061-4. PubMed ID: 12168901
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic relevance of metastatic renal cell carcinoma in the head and neck: An evaluation of 22 cases in 671 patients.
Lieder A; Guenzel T; Lebentrau S; Schneider C; Franzen A
Int Braz J Urol; 2017; 43(2):202-208. PubMed ID: 27649110
[TBL] [Abstract][Full Text] [Related]
6. Metastatic renal cell carcinoma to the head and neck: summary of 21 cases.
Langille G; Taylor SM; Bullock MJ
J Otolaryngol Head Neck Surg; 2008 Aug; 37(4):515-21. PubMed ID: 19128586
[TBL] [Abstract][Full Text] [Related]
7. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.
Cangiano T; Liao J; Naitoh J; Dorey F; Figlin R; Belldegrun A
J Clin Oncol; 1999 Feb; 17(2):523-8. PubMed ID: 10080595
[TBL] [Abstract][Full Text] [Related]
8. Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma (RCC) with small primary tumours treated with sunitinib or interferon-α.
Tsimafeyeu I; Zart JS; Chung B
BJU Int; 2013 Jul; 112(1):32-8. PubMed ID: 23746142
[TBL] [Abstract][Full Text] [Related]
9. Metastatic Renal Cell Carcinoma of the Head and Neck: A Case Series.
Lam HP; Addicks BL; Farmer RW; Fancy T
W V Med J; 2017; 113(2):48-51. PubMed ID: 29373783
[TBL] [Abstract][Full Text] [Related]
10. Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma.
Kwak C; Park YH; Jeong CW; Jeong H; Lee SE; Moon KC; Ku JH
J Surg Oncol; 2007 Mar; 95(4):317-23. PubMed ID: 17066434
[TBL] [Abstract][Full Text] [Related]
11. Metastatic renal cell carcinoma of the spine: surgical treatment and results.
Jackson RJ; Loh SC; Gokaslan ZL
J Neurosurg; 2001 Jan; 94(1 Suppl):18-24. PubMed ID: 11147860
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of combined immunotherapy with low-dose interleukin-2 and interferon-alpha for Japanese patients with metastatic renal cell carcinoma who had undergone radical nephrectomy: a preliminary report.
Miyake H; Hara I; Sakai I; Harada K; Inoue TA; Eto H; Takechi Y; Fujisawa M
Int J Clin Oncol; 2005 Oct; 10(5):338-41. PubMed ID: 16247661
[TBL] [Abstract][Full Text] [Related]
13. [Distant metastasis of renal cell carcinomas to the head-neck area].
Issing PR; Heermann R; Ernst A; Kuske M; Lenarz T
Laryngorhinootologie; 1996 Mar; 75(3):171-4. PubMed ID: 8652034
[TBL] [Abstract][Full Text] [Related]
14. EORTC-GU group expert opinion on metastatic renal cell cancer.
de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M
Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861
[TBL] [Abstract][Full Text] [Related]
15. Metastatic renal cell carcinoma to the hyoid bone.
Lee HS; Lee JH; Kim SW; Lee KD
Otolaryngol Head Neck Surg; 2010 Jun; 142(6):913-4. PubMed ID: 20493369
[No Abstract] [Full Text] [Related]
16. Treatment of bone metastases and local recurrence from renal cell carcinoma with immunochemotherapy and radiation.
Brinkmann OA; Bruns F; Gosheger G; Micke O; Hertle L
World J Urol; 2005 Jul; 23(3):185-90. PubMed ID: 15838689
[TBL] [Abstract][Full Text] [Related]
17. Complete response in a cutaneous facial metastatic nodule from renal cell carcinoma after hypofractionated radiotherapy.
Gay HA; Cavalieri R; Allison RR; Finley J; Quan WD
Dermatol Online J; 2007 Oct; 13(4):6. PubMed ID: 18319003
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive nephrectomy vs medical therapy as initial treatment: a rational approach to the sequence question in metastatic renal cell carcinoma.
Spiess PE; Fishman MN
Cancer Control; 2010 Oct; 17(4):269-78. PubMed ID: 20861814
[TBL] [Abstract][Full Text] [Related]
19. Possible synergy of radiotherapy and chemo-immunotherapy in metastatic renal cell carcinoma (RCC).
Brinkmann OA; Bruns F; Prott FJ; Hertle L
Anticancer Res; 1999; 19(2C):1583-7. PubMed ID: 10365150
[TBL] [Abstract][Full Text] [Related]
20. Metastatic renal cell carcinoma to the head and neck.
Pritchyk KM; Schiff BA; Newkirk KA; Krowiak E; Deeb ZE
Laryngoscope; 2002 Sep; 112(9):1598-602. PubMed ID: 12352670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
